Morningstar Quantitative ratings for equities (denoted on this page by) are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies withratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating. Click here for more on how to use these ratings.
E-Qure Corp is a medical device company. The company plans to commercialize its Bioelectrical Signal Therapy(BST) device. Its device treats wounds via electrical stimulation, which is believed to result in accelerated wound healing by imitating the natural electrical current that occurs in injured skin on the human body. BST Device is designed to treat chronic wounds - primarily Stage III and Stage IV ulcers.
New York, NY, 10023